RMD News: CLPT Stock Gains on FDA Clearance for Navigation Software Version 3.0 - 28th Jan 2025, 10:19pm

[annb0t]

ClearPoint Neuro, Inc. CLPT, a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, recently received FDA’s 510(k) clearance for its ClearPoint Navigation Software Version 3.0. ClearPoint Navigation Version 3.0 is one of the fastest and most accurate navigation systems available while enabling the flexibility to be used in both the MRI suite and the operating room.

Per management, the latest development will benefit its more than 50 glo...

>>> Read more: CLPT Stock Gains on FDA Clearance for Navigation Software Version 3.0